Completed PHASE3 INTERVENTIONAL 4-arm NCT00021814

Medical Therapy of Prostatic Symptoms (MTOPS)

Sponsor: George Washington University

Conditions Prostatic Hyperplasia Prostatic Hypertrophy, Benign

Interventions Doxazosin Doxazosin placebo Finasteride Finasteride placebo

Updated 7 times since 2017 Last updated: Sep 26, 2018 Started: Dec 31, 1995 Primary completion: Nov 30, 2001 Completion: Nov 30, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Prostatic Hyperplasia and Prostatic Hypertrophy, Benign, this trial is completed. The trial is conducted by George Washington University and has accumulated 7 data snapshots since 1995. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Oct 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Oct 2018 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

George Washington University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Data source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Aurora, United States , Baltimore, United States , Chicago, United States , Dallas, United States , Detroit, United States , Houston, United States , Iowa City, United States , La Jolla, United States , Nashville, United States and 6 more locations